Nevada Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Tech Journal.

Press releases published on July 8, 2026

2 hours ago

UK businesses drastically overestimate their AI progress

Indeterminate GlobeNewswire

2 hours ago

ESET Threat Report: AI boosts cyber attackers’ efficiency

Indeterminate GlobeNewswire

3 hours ago

Herstel is de benchmark van veerkracht

Indeterminate GlobeNewswire

3 hours ago

AMSilk and Ajinomoto Foods Europe Expand Partnership to Enable Industrial-Scale Production of Silk Proteins

Indeterminate GlobeNewswire

4 hours ago

The Board Decision Gap: AI Transforms the Deal, But Boards Still Govern the Outcome

Indeterminate GlobeNewswire

4 hours ago

On World Obesity Day, WONDERLAB Releases the Targeted Microbiota Weight Management White Paper

Indeterminate GlobeNewswire

6 hours ago

New Prop Firm DojoTraders Launches and Aims to Simplify Trading Across Markets

Indeterminate GlobeNewswire

6 hours ago

Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness

Indeterminate GlobeNewswire

7 hours ago

Snail Games 推出《方舟：创世崛起》第一部分、《方舟：命运之潮》及《方舟：龙之乌托邦》DLC；1,100 万美元递延收入积压将于 2026 年第三季度确认

Indeterminate GlobeNewswire

7 hours ago

Snail Games 推出《方舟：創世崛起》第一部分、《方舟：財富之潮》及《方舟：龍之烏托邦》可下載內容；遞延收入積壓中的 1,100 萬美元將於 2026 年第三季度確認

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical conclut un accord avec Novo Nordisk pour évaluer le NPM-139, un implant miniature à base de sémaglutide à action ultra-prolongée destiné au traitement de l’obésité

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical Mengadakan Perjanjian dengan Novo Nordisk untuk Mengevaluasi NPM-139, Implan Semaglutide Miniatur dengan Kerja Sangat Panjang untuk Pengelolaan Berat Badan Kronis

Indeterminate GlobeNewswire

7 hours ago

ヴィヴァニ・メディカル、慢性体重管理のためのセマグルチドの超長時間作用小型インプラント「NPM-139」の評価に向け、ノボ ノルディスクと契約を締結

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical, 만성 체중관리용 초장기 지속형 세마글루타이드 임플란트 'NPM-139' 평가 위해 Novo Nordisk와 계약 체결

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical Menandatangani Perjanjian dengan Novo Nordisk bagi Menilai NPM-139, Implan Semaglutide Miniatur dengan Tindakan Ultra Jangka Panjang bagi Pengurusan Berat Badan Kronik

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical เข้าทำข้อตกลงกับ Novo Nordisk เพื่อประเมิน NPM-139…

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical 与 Novo Nordisk 达成协议，评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139

Indeterminate GlobeNewswire

7 hours ago

Vivani Medical 與 Novo Nordisk 達成協議，評估一種微型、超長效並用於慢性體重管理的司美格魯肽植入劑 NPM-139

Indeterminate GlobeNewswire

9 hours ago

Alamar Biosciences 推出首个针对 eMTBR-Tau 的多重血液免疫检测，后者是阿尔茨海默病研究中最重要的生物标志物之一

Indeterminate GlobeNewswire